Halozyme
HALO
166 hedge funds and large institutions have $1.71B invested in Halozyme in 2015 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 64 increasing their positions, 57 reducing their positions, and 27 closing their positions.
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
32% more call options, than puts
Call options by funds: $29.4M | Put options by funds: $22.4M
30% more capital invested
Capital invested by funds: $1.32B → $1.71B (+$394M)
12% more repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 57
5% less funds holding
Funds holding: 175 → 166 (-9)
30% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 27
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$22M |
| 2 |
Bank of New York Mellon
New York
|
+$20.4M |
| 3 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
+$7.97M |
| 4 |
LOAMS
Lombard Odier Asset Management (Switzerland)
Petit-Lancy,
Switzerland
|
+$7.65M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.42M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$47.7M |
| 2 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$9.49M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$3.81M |
| 4 |
Two Sigma Investments
New York
|
-$3.09M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$3.03M |
HALO Hedge Fund Activity: Q4 2015 in Review
166 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q4 2015, worth a combined $1.71B — up 30% from $1.32B a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of HALO and 19 opened new positions — a net loss of 8 holders — while 57 trimmed existing stakes and 64 added.
The largest buyer was Fidelity Investments, adding an estimated $22M. The largest seller was Millennium Management, cutting an estimated $47.7M.
- 166 institutional investors held Halozyme (HALO) as of Q4 2015, down from 175 in Q3 2015.
- Funds reported $1.71B of Halozyme stock for Q4 2015, up 30% quarter-over-quarter.
- 19 funds opened new Halozyme positions in Q4 2015 and 27 closed out, a net change of -8 holders.
- The largest Halozyme buyer in Q4 2015 was Fidelity Investments, an estimated $22M added.
- The largest Halozyme seller in Q4 2015 was Millennium Management, an estimated $47.7M sold.
Based on aggregated 13F filings for Q4 2015.